LegiEquity
Sign In
2025-2026 Regular Session • New York Legislature

A01248

Legislative Summary

Prohibits the knowing sale of xylazine above a certain weight to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

Demographic Impact

Overall analysis of equity impact

70% Positive
High ConfidenceView detailed demographic breakdown ↓

Unlock Full Demographic Insights

Go beyond the overall score.

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Contact Sales to Learn More

Or email us directly at sales@legiequity.us.

Bill History

1/9/2025
referred to consumer affairs and protection
Assembly
3/25/2025
reported referred to codes
Assembly
4/2/2025
reported referred to ways and means
Assembly
4/21/2025
amend (t) and recommit to ways and means
Assembly
4/21/2025
print number 1248a
Assembly

Roll Call Votes

Assembly Codes Committee: Favorable refer to committee Ways and Means
4/2/2025
20
Yea
0
Nay
0
Not Voting
2
Absent
Result: PASSED
Assembly Consumer Affairs And Protection Committee: Favorable refer to committee Codes
3/25/2025
15
Yea
0
Nay
0
Not Voting
1
Absent
Result: PASSED

Status Information

Current Status
Introduced(1/9/2025)
Chamber
Assembly
Committee
Ways and Means(Assembly)

Sponsors

Democrat: 18
Republican: 5

Primary Sponsor

Yudelka Tapia
Yudelka Tapia
Democrat

Documents

Introduced
Bill Text • 1/9/2025 • 4.2 KB
LegiScanState Site
Amended
Bill Text • 1/9/2025 • 4.8 KB
LegiScanState Site

External Links

View on LegiScanView on State Website